Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Non Operating Income (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Non Operating Income for 4 consecutive years, with $2678.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 113.16% to $2678.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.3 million through Dec 2025, down 5644.49% year-over-year, with the annual reading at -$4.3 million for FY2025, 5644.49% down from the prior year.
  • Non Operating Income for Q4 2025 was $2678.0 at bioAffinity Technologies, up from -$2.8 million in the prior quarter.
  • The five-year high for Non Operating Income was $42764.0 in Q2 2023, with the low at -$2.8 million in Q3 2025.
  • Average Non Operating Income over 4 years is -$419826.2, with a median of -$20344.0 recorded in 2024.
  • Peak annual rise in Non Operating Income hit 113.16% in 2025, while the deepest fall reached 11183.35% in 2025.
  • Over 4 years, Non Operating Income stood at -$1.1 million in 2022, then soared by 97.52% to -$28466.0 in 2023, then grew by 28.53% to -$20344.0 in 2024, then surged by 113.16% to $2678.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $2678.0, -$2.8 million, and -$1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.